Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Crispr Therapeutics AG (1CG) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:1CGCrispr Therapeutics AGCHF 34.43CHF 3.19B-8.21-23.58%Moderate BuyUnlock the CH:1CG analyst price target with TipRanks PremiumCH:1CGUnlock the CH:1CG top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$9.52$1.34B-2.8415.53%HoldUnlock the NTLA analyst price target with TipRanks PremiumCH:1CG vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
BEAMBeam Therapeutics$20.94$2.17B-20.94-0.19%Strong BuyUnlock the BEAM analyst price target with TipRanks PremiumCH:1CG vs BEAMUnlock the BEAM top-analyst price target with TipRanks Premium
LEGNLegend Biotech$16.10$3.12B-1610.00-42.50%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumCH:1CG vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$119.39$10.19B-32.8984.19%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumCH:1CG vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:1CGCrispr Therapeutics AG34.43-10.62-23.58%
NTLAIntellia Therapeutics9.521.4818.41%
BEAMBeam Therapeutics20.940.341.65%
LEGNLegend Biotech16.10-11.43-41.52%
KYMRKymera Therapeutics119.3954.7684.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts